Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.

Saved in:

Bibliographic Details
Title:	Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells.
Authors:	Matsuzawa, Fumihiko¹ (AUTHOR), Kamachi, Hirofumi¹ (AUTHOR) hkamachi@db3.so-net.ne.jp, Mizukami, Tatsuzo¹ (AUTHOR), Einama, Takahiro² (AUTHOR), Kawamata, Futoshi¹ (AUTHOR), Fujii, Yuki¹ (AUTHOR), Fukai, Moto¹ (AUTHOR), Kobayashi, Nozomi¹ (AUTHOR), Hatanaka, Yutaka³ (AUTHOR), Taketomi, Akinobu¹ (AUTHOR)
Source:	BMC Cancer. Dec2021, Vol. 21 Issue 1, p1-16. 16p.
Database:	Academic Search Ultimate

Description
ISSN:	14712407
DOI:	10.1186/s12885-020-07722-3